Anaphylactic reaction to etoposide phosphate

Pediatric Blood and Cancer

Volumn 59, Issue 4, 2012, Pages 765-765

  Lindsay, Holly ^a   Gaynon, Paul ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ETOPOFOS; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ANAPHYLAXIS; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FLACCID PARALYSIS; HUMAN; HUMAN TISSUE; HYPOTENSION; LETTER; PRESCHOOL CHILD; PRIORITY JOURNAL; TACHYCARDIA; URTICARIA;

ANAPHYLAXIS; ANTINEOPLASTIC AGENTS; ETOPOSIDE; FEMALE; HUMANS; INFANT; LEUKEMIA; ORGANOPHOSPHORUS COMPOUNDS; SKIN NEOPLASMS;

EID: 84864944114     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24183     Document Type: Letter

References (7)

1. Collier K, Schink C, Young AM, et al. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity. J Oncol Pharm Pract 2008; 14: 51-55.
2. De Souza P, Friedlander M, Wilde C, et al. Hypersensitivity reactions to etoposide: A report of three cases and review of the literature. Am J Clin Oncol 1994; 17: 387-389.
3. Hartmann JT, Lipp HP. Camptothecin and podophyllotoxin derivatives: Inhibitors of topoisomerase I and II-Mechanisms of action, pharmacokinetics, and toxicity profile. Drug Saf 2006; 29: 209-230.
4. Bernstein BJ, Troner MB. Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide. Pharmacotherapy 1999; 19: 989-991.
5. Siderov J, Prasad P, De Boer R, et al. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide. Br J Cancer 2002; 86: 12-13.
6. Coors EA, Seybold H, Merk HF, et al. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol 2005; 95: 593-599.
7. ten Tije AJ, Verweig J, Loos WJ, et al. Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy. Clin Pharmacokinet 2003; 42: 665-685.